VANDERBILT UNIVERSITY MEDICAL CENTER
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis
Immunologic and Antigenic Drivers of Immune Checkpoint Inhibitor-Associated Myocarditis is a funding opportunity from VANDERBILT UNIVERSITY MEDICAL CENTER, up to 805488, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
Project Summary/Abstract This proposal brings together Dr. Javid Moslehi, a cardio-oncologist and myocyte biologist, and Dr. Justin Balko, a cancer biologist and immunologist, to define the immunologic and antigenic drivers of myocarditis associated with cancer immunotherapies. Specifically, immune checkpoint…